NAD+: What the Clinical Trials Actually Show
Last updated: March 2026
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme essential to cellular energy metabolism, DNA repair, and sirtuin signaling. By age 60, most people have roughly half the NAD+ they had at 20 — due to decreased biosynthesis (NAMPT activity drops) and increased consumption (PARP enzymes and CD38 increase with age). Human trials show NMN and NR safely raise NAD+ levels.
📋 On this page
What Is NAD+?
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every living cell. First described in 1906, it sits at the intersection of the cell's most essential functions. Without adequate NAD+, cells can't make energy, repair DNA, or regulate aging pathways effectively.
Energy Metabolism
Central to converting food into cellular energy (ATP). Required by mitochondria for the electron transport chain.
DNA Repair
Fuels PARP enzymes that repair DNA damage. More damage = more NAD+ consumed — creating a vicious cycle with age.
Cellular Signaling
Activates sirtuins (SIRT1–7), the "longevity genes" that regulate inflammation, stress response, and metabolism.
Cellular Cleanup
Required for autophagy — your cells' garbage collection system that removes damaged components and recycles them.
Why NAD+ Declines With Age
By age 60, most people have roughly half the NAD+ they had at 20. This isn't one cause — it's a double hit: biosynthesis slows down while consumption accelerates.
NAD+ declines because of two forces: decreased biosynthesis (NAMPT enzyme activity drops) AND increased consumption (more DNA damage = more PARP activity eating NAD+, plus CD38 enzyme increases with age).
— Khatri, Abdellatif & Sedej, Geromedicine 2025
The Four Precursor Pathways
Your body can't absorb NAD+ directly — it needs to be synthesized from precursors. Four main compounds have been studied in humans, each entering the biosynthesis pathway at a different step.
NMN (Nicotinamide Mononucleotide)
Direct precursor to NAD+. One enzymatic step away.
NR (Nicotinamide Riboside)
Patented as Niagen/Tru Niagen. Two steps from NAD+.
Niacin / Nicotinic Acid (NA)
The cheapest NAD+ precursor. Vitamin B3 you've had your whole life.
NAM (Nicotinamide)
Most common dietary form. Found in fortified foods everywhere.
What the Clinical Trials Actually Found
From the 2025 systematic review (Geromedicine, Khatri et al.) — the most comprehensive synthesis of human NAD+ trial data to date. Here's what the science actually supports.
✅ Consistently Demonstrated
- NAD+ precursors are safe and well-tolerated in humans
- Oral NR and NMN do raise blood NAD+ levels measurably
- No serious adverse effects in completed trials
⚠️ Mixed or Limited
- Physical performance improvements: modest and inconsistent
- Muscle mass/strength effects: non-significant in meta-analysis
- Cognitive benefits: not yet demonstrated in large trials
- Many trials focused on safety, not clinical outcomes
- Healthy, fit individuals may see little benefit from boosting
❌ Not Yet Demonstrated
- Lifespan extension in humans
- Reversal of biological aging
- Consistent clinical outcomes across large populations
The gap between the hype and the evidence is real. Animal studies are spectacular — NAD+ boosts reverse aging markers in mice consistently. But human trials have been smaller, shorter, and focused mostly on proving safety and bioavailability. We're at the 'promising but early' stage.
Not All NAD+ Is Equal
How you get NAD+ into your body matters enormously. Per Dr. Craig Koniver and Andrew Huberman's firsthand clinical and personal experience, the delivery method is often more important than the dose.
IV Infusion — Gold Standard
750mg loading dose. Koniver's #1 pick. Works "almost inexplicably" to go from sick to well. Huberman recovered from COVID in 48 hours. Cost: $500–1,000/session, monthly maintenance. Uncomfortable — some patients need anti-nausea medication during infusion.
Injection (SubQ/IM)
Next best option. More accessible than IV infusions. Better bioavailability than any oral form. Good middle ground for those who can't access or afford IV.
NMN (Oral) — Best Oral Option
Best oral option per Koniver. Closer to NAD+ in the biosynthesis pathway than NR, meaning fewer conversion steps. The practical choice for most people.
NR (Oral)
Most studied oral form. Can reduce inflammation. Less effective than NMN per Koniver, but has the deepest base of human safety data. Two steps from NAD+.
NAD+ Direct (Oral)
Poor oral bioavailability. NAD+ is not well absorbed through the GI tract. The molecule is degraded before it can enter circulation in meaningful amounts.
"If I had to pick one thing for people, engaging in NAD would be it."
What Koniver & Huberman Actually Said
Dr. Craig Koniver is a functional medicine physician with one of the largest IV NAD+ clinical practices in the US. His October 2024 appearance on Huberman Lab is the most detailed clinical overview available.
IV NAD+ — Clinical Reality
Koniver calls the transformation from IV NAD+ "almost inexplicable" — patients going from debilitated to functional. Huberman used it to recover from COVID in 48 hours. The anecdotal signal is strong even where RCT data is thin.
The Oral Hierarchy
Koniver's clear preference: NMN over NR over direct NAD+ for oral supplementation. His reasoning: proximity to NAD+ in the biosynthesis pathway. The fewer enzymatic steps, the better the conversion efficiency.
Who Benefits Most
Koniver and the 2025 systematic review both note: people with lower baseline NAD+ (older, sick, or metabolically compromised) see the most benefit. Healthy, fit individuals may have little room for improvement.
The Hair & Nails Test
Koniver's informal biomarker: patients on NMN report noticeably faster hair and nail growth — a proxy signal for cellular proliferation and metabolic activity. Anecdotal but widely reported.
NAD+ Precursors in Food
Diet alone won't replicate supplemental doses, but these foods contribute meaningful amounts of niacin and other NAD+ precursors.
Safety: What the Trials Show
Across completed human trials, the overall safety picture is reassuring. No serious adverse effects have been reported. But there are nuances worth knowing.
Oral NR / NMN — Well Tolerated Minor GI symptoms (nausea, loose stools) reported in a small subset of participants. Consistently well-tolerated at recommended doses across all completed trials.
IV NAD+ — Uncomfortable, Not Dangerous IV infusions are frequently described as uncomfortable — flushing, pressure sensations, nausea. Some patients require anti-nausea medication. Not dangerous, but not painless either.
Niacin — Flushing is Common Skin flushing (redness, warmth, itching) is well-documented at higher doses. Can be reduced with slow-release formulations or aspirin pretreatment. Not dangerous in most people.
Niacin — Cardiovascular Signal to Watch One correlative study suggested excessive niacin intake may increase cardiovascular inflammation markers. Evidence is preliminary and correlative — not yet sufficient to change clinical guidance, but warrants monitoring.
Overall: No Serious Adverse Effects in Clinical Trials The 2025 systematic review (Khatri et al.) found no serious adverse events across completed human NAD+ precursor trials. This is the single most important safety finding: the evidence supports a clean short-term safety profile.
Key Takeaways
Where does the science actually land? Here's the honest split between what's established and what's still speculation.
✅ What We Know
- NAD+ declines with age — well-established across species
- Oral precursors (NR, NMN) safely raise blood NAD+ levels
- IV NAD+ has dramatic anecdotal clinical results (Koniver, Huberman)
- Safety profile is clean across completed human trials
- NAD+ is central to energy, DNA repair, and cellular signaling
⚠️ What We Don't Know Yet
- Whether raising NAD+ in healthy people produces meaningful clinical benefits
- Long-term effects of chronic supplementation
- The optimal precursor, dose, and delivery route
- Whether supplements actually extend healthspan in humans
- Cost-effectiveness: IV $500–1,000/session; supplements $30–100/month
- Whether spectacular animal results will translate to humans
Sources
- Khatri S, Abdellatif M, Sedej S. "Clinical evidence for the use of NAD+ precursors to slow aging." Geromedicine. 2025. — Primary systematic review referenced throughout this guide.
- PMC12022230 — NMN/NR skeletal muscle meta-analysis. 2025. Found muscle mass and strength effects were non-significant across pooled trials.
- Huberman Lab Podcast — Dr. Craig Koniver episode, October 2024. Clinical practice perspective on IV NAD+, precursor hierarchy, and practical implementation.
- StatPearls — NAD+ metabolism reference. Comprehensive biochemistry background on biosynthesis pathways, enzyme kinetics, and sirtuin activation.
Related Guides
💊 NAD+ Precursor Supplements
Stack with these research-backed NAD+ precursors
Affiliate links help support HighPeptides at no extra cost to you.
Want the Complete Protocol Guide?
Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.
Get the Guide →
Educational content only. Not medical advice. This page is for informational purposes. NAD+ precursors (NMN, NR) are sold as dietary supplements, not FDA-approved treatments. IV NAD+ is administered in clinical settings. The research reviewed here includes preliminary and observational studies — do not interpret as established treatment guidelines. Always consult with a qualified healthcare provider before starting any supplementation protocol.